In the News

KAHALA BIOSCIENCES, RYMEDI BRING BLOCKCHAIN TO COVID-19 ANTIBODY TESTING

May 27, 2020 – Widespread testing is going to be key to safely reopening businesses and global economies in the current pandemic. To that end, Kahala Biosciences LLC, an Irvine, Calif.-based testing and tracking startup, and its technology partner, Rymedi Inc., of Greenville, S.C., have launched the Adiona COVID-19 antibody testing platform…

ADIONA COVID-19 ANTIBODY TEST PLATFORM BECOMES FIRST U.S. SOLUTION TO MARRY ANTIBODY TESTING AND BLOCKCHAIN TECHNOLOGY

May 18, 2020 – Kahala Biosciences LLC… and technology partner Rymedi, Inc., a Greenville, South Carolina-based developer of blockchain-based protocols and solutions for complex life sciences and pharmaceuticals…

COVID-19 ANTIBODY TEST REVEALS IT WAS ‘ALL IN THE FAMILY’

May 7, 2020 – A San Carlos family participated in an antibody test with surprising results: all four members had previous COVID-19 infections

STARTUPS & INNOVATIONS

May 4, 2020 – Koa Accel, an Irvine-based medtech accelerator, has launched a new portfolio company with an initial seed investment to tackle COVID-19 testing needs.

MAKANI SCIENCE RECEIVES FIRST INVESTMENT FROM KOA ACCEL

April 22, 2020 – Today Makani Science™, a developer of the only wireless sensor designed to non-invasively monitor a sedated patient’s breathing rate and volume during medical or dental procedures…

MED-DEVICE ACCELERATOR OPERATES MORE LIKE A BOUTIQUE PRIVATE EQUITY FIRM

December 19, 2019 – Koa Accel claims it can accelerate timeline for investors, save money and de-risk the investments…

EXEC CHAT: KOA ACCEL LEARNS FROM PAST MISTAKES TO HELP MEDTECH INVENTORS (PART 1)

December 5, 2019 – Koa Accel CEO Francis Duhay outlines his company’s plans to take some of the risk out of investing in medical device start-ups by…

EXEC CHAT: KOA ACCEL LEARNS FROM PAST MISTAKES TO HELP MEDTECH INVENTORS (PART 2)

December 5, 2019 – Koa Accel CEO Francis Duhay tells Medtech Insight what his company looks for when choosing medtech ideas to support and how his experience as a physician and inventor informs his investment strategy.

MEDICAL DEVICE ACCELERATOR UNVEILED

September 30, 2019 – Koa Accel, a recently unveiled accelerator for early-stage medical device startups, is better on its experienced team to achieve success…

FAMILIAR START, WITH MAKANI, MICRODERMICS

September 30, 2019 – Koa Accel didn’t have to look too far for one of its first investments…

KOA ACCEL LAUNCHES AS NEW TYPE OF MEDICAL DEVICE ACCELERATOR, EMBEDDING EXPERT, INVESTED TEAMS TO DRIVE INNOVATIONS FORWARD

September 12, 2019 – In a move to develop medical devices faster, at a lower cost, and with a greater likelihood of a successful exit…

PRESS RELEASES

April 22, 2020

IRVINE-BASED MEDTECH ACCELERATOR KOA ACCEL LAUNCHES KAHALA BIOSCIENCES, NEW PORTFOLIO COMPANY DESIGNED TO MEET URGENT U.S. NEED FOR EFFECTIVE, AVAILABLE COVID-19 TESTING

September 18, 2019

MICRODERMICS APPOINTS FRANCIS DUHAY, MD, AS CHIEF EXECUTIVE OFFICER

September 12, 2019

KOA ACCEL LAUNCHES AS NEW TYPE OF MEDICAL DEVICE ACCELERATOR, EMBEDDING EXPERT, INVESTED TEAMS TO DRIVE INNOVATIONS FORWARD, FASTER, TO REDUCE INVESTOR RISK